Gujarat Themis Biosyn informs about appointment of CFO

05 Jan 2023 Evaluate

Gujarat Themis Biosyn has informed that the Board of Directors at its meeting held today, considered and approved the appointment of Tapas Guha Thakurata as the Chief Executive Officer (CEO) of the Company– Key Managerial Personnel under the provisions of the Companies Act, 2013 and rules there under. The company has annexed the disclosures pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) 2015 read with SEBI circular no CIR/CFD/CMD/4/2015 dated 09th September, 2015 relating to appointment of Tapas Guha Thakurata as the CEO (Annexure I). The company has commenced from 10:30 am and concluded on 10:48 am.

The above information is a part of company’s filings submitted to BSE.

Guj. Themis Biosyn Share Price

263.75 18.20 (7.41%)
11-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1687.55
Dr. Reddys Lab 1109.15
Cipla 1463.15
Lupin 1969.05
Zydus Lifesciences 868.25
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...